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1. Introduction 
 
1.1 Background 
 
Both inadequate and excessive depth of anaesthesia due to inappropriate anaesthetic 
drugs delivery during general anaesthesia may compromise patients’ outcome (Bruhn 
et al., 2006; Buhre and Rossaint, 2003; Monk et al., 2005). Hence, individualizing 
anaesthesia to minimize both over- and underdosage of anaesthetic drugs 
administration during general anaesthesia is the pursuit of modern anaesthetic 
practice.  
 
To reach an appropriate anaesthetic drug delivery, the most important issue is to use 
indicator(s) that can monitor accurately depth of anaesthesia to guide titrating 
anaesthetics during general anaesthesia. In routine clinical practice, the dosage of 
anaesthetic drugs is usually adjusted according to the patient’s cardiovascular and 
vegetative response to surgical stimuli, such as blood pressure, heart rate, sweating, 
tear production (Buhre and Rossaint, 2003) and movement. However, the vegetative 
response to surgery is affected by many confounding factors such as α or β agonists or 
blockers used during surgery and is extremely changeable in the individual patient 
(Struys et al., 2002). Patient movement in response to noxious stimulation remains an 
important sign of inadequate depth of anaesthesia, but is also unreliable and is 
suppressed by muscle relaxants (Sandin et al., 2000). Therefore, continuing efforts 
have been taken by anesthesiologists to try to develop more reliable methods for 
monitoring depth of anaesthesia. So far some methods have been proposed and tested 
for assessing the depth of anaesthesia, which include mainly 
electroencephalogram(EEG)-derived variables such as spectral edge frequency 95 
(SEF95), median power frequency, approximate entropy and bispectral index (BIS), 
auditory-evoked potential (AEP), and heart-rate variability (HRV). 
 
It is well known that general anaesthesia is a state of unconsciousness induced by 
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anaesthetic agents and includes three components, hypnosis (loss of consciousness), 
analgesia (pain relief) and immobilization. It is difficult or impossible to measure all 
the three components with one variable. A variety of variables have been proposed to 
monitor depth of hypnosis. Most of them are EEG-derived variables, such as BIS 
(Bispectral Index Monitor, Aspect Medical Inc., Newton, MA, USA), the Narcotrend 
index (Narcotrend Monitor, Schiller AG, Baar, Switzerland), State and Response 
Entropy (GE Healthcare Finland, Helsinki, Finland) and AEP (A-line AEP monitor, 
Danmeter, Odense, Denmark), which are the most established monitors and have been 
proved to offer mainly information about the hypnotic state, but have limited efficacy 
in measuring adequacy of analgesia of the patient during general anaesthesia (Bruhn 
et al., 2003); (Glass et al., 1997; Struys et al., 2002). Some recent studies have 
suggested that use of these monitors for guidance of anaesthetics delivery could allow 
exact dosage of anaesthetic drugs (hypnotics), improve early recovery from 
anaesthesia, and decrease the frequency of unwanted events during general 
anaesthesia (Aime et al., 2006; Bruhn et al., 2005; Gruenewald et al., 2007; Vakkuri et 
al., 2005).  
 
Analgesia is defined as the relief of pain, in other words, as absence of pain in 
response to stimulation that would normally be painful (Guignard, 2006). However 
this definition is subjective because the pain itself is a subjective sensation and is a 
descriptor of a conscious, emotional, private experience induced by a wide variety of 
events such as surgical damage. During general anaesthesia, the conscious experience 
of pain disappears. Therefore, in an anesthetized patient it is not appropriate to call the 
physiological reaction to tissue injury by surgery as “pain”. Some authors (Rantanen 
et al., 2006; Struys et al., 2007) used an alternative term of “nociception” to substitute 
the term of “pain” during general anaesthesia in their papers.  The term 
“nociception” covers all activity caused by tissue damage from the peripheral sensory 
afferent to the brainstem level, where nociception may become apparent as 
cardiovascular or hormonal responses (Desborough, 2000; Yaksh, 1998).  
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It is well accepted that excessive intraoperative stress (nociception) results in various 
physiological changes such as immunological and haemodynamic changes or 
endocrine ‘stress response’, which thereby may influence patients’ outcome, length of 
hospital stay, and overall costs of hospital care (Myles et al., 2002; Parker et al., 1995; 
Roizen et al., 1981). On the other hand, analgesics such as opioids may blunt the 
stress response during surgery by reducing the transmission of peripheral nociceptive 
stimuli to the central nervous system, preventing spinal reflexes, and disrupting the 
complex pathways in the autonomic nervous system (Urban, 2002). Therefore, to 
achieve an appropriate balance of nociception – anti-nociception during general 
anaesthesia is an important issue. 
 
Similar to the depth of anaesthesia, achieving an appropriate depth of analgesia 
(anti-nociception) depends on accurate assessing of the balance of nociception – 
anti-nociception which then could be used for guiding analgesic delivery during 
general anaesthesia.  
 
Numerous of methods have been proposed for assessing the balance of nociception – 
anti –nociception during general anaesthesia. More commonly used methods are 
based on isolated, unspecific autonomic reactions, such as the presence or absence of 
hypertension, tachycardia, or sweating and tearing, which have been proved to be 
unreliable with a low specificity (Bruhn et al., 2006; Heier and Steen, 1996; Rantanen 
et al., 2006). Some surrogate measures derived from the spontaneous EEG such as the 
state and response entropy (SE and RE) have been validated as measures of the 
hypnotic component of anaesthesia, but have limited accuracy for assessing of 
nociception - anti-nociception (Huang et al., 2006; Struys et al., 2002; Struys et al., 
2003; Vanluchene et al., 2004). One alternative experimental method to estimate only 
the anti – nociception side of the balance is to determine directly or to model plasma 
concentration of opioids (Bouillon et al., 2004). Several other methods, including 
suppression of photoplethysmographic pulse wave amplitude (Rantanen et al., 2006; 
Seitsonen et al., 2005), activation of facial muscles (Hynynen et al., 1985; Takamatsu 
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et al., 2006), changes in skin conductivity (Storm et al., 2002), skin vasomotor 
reflexes (Shimoda et al., 1997) and pupillometry (Ibrahim et al., 2003; Taylor et al., 
2003), have also been proposed to assess the nociception - anti-nociception balance. 
Unfortunately, all measures of nociception – anti-nociception balance mentioned 
above are subject to inter-individual variability, non-specific, lack sensitivity to actual 
nociception and are generally without real prediction (Luginbuhl et al., 2006; 
Luginbuhl et al., 2007; Mathews et al., 2007). More recently, Bonhomme et al. 
(Bonhomme et al., 2006) tried to use combination of BIS and A-Line Autoregressive 
Index (AAI) monitor to assess nociception – anti-nociception balance during propofol 
– remifentanil anaesthesia and found that during a BIS-guided constant level of 
hypnosis, AAI response to the onset of surgical stimulation significantly differed 
according to the analgesia regimen. However, the sensitivity and specificity of AAI in 
assessing the balance of nociception – anti –nociception should be further refined. 
Therefore, a validated numeric dimension of nociception – anti – nocicetpion balance 
during general anaesthesia is currently not available (Wennervirta et al., 2008). 
 
Surgical stress index (SSI), a novel multivariate index based on the sum of the 
normalized heart beat interval (HBI) and the pulse wave amplitude (PPGA) time 
series of the photoplethysmography (PPG), has been developed to assess the 
nociception – anti-nociception balance during general anaesthesia (Huiku et al., 2007). 
In the study performed by Huiku et al., SSI was showed to have a negative correlation 
with remifentanil effect-site concentration (Ceremi) and a positive correlation with the 
intensity of stimulus during total intravenous anaesthesia with propofol and 
remifentanil (Huiku et al., 2007). Ahonen et al. also found that SSI reacted well to the 
level of surgical stress and β-blocker (Esmolol) administration did not influence SSI 
values during general anaesthesia (Ahonen et al., 2007). Struys et al. and Wennervirta 
et al. further proved that SSI appeared to have a better performance in detecting 
nociceptive stimuli during general anaesthesia than state entropy (SE), response 
entropy (RE), heart rate, or PPGA (Struys et al., 2003; Wennervirta et al., 2008). 
Though all of the above references suggest that SSI might be used for guidance of 
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remifentanil delivery during general anaesthesia, unfortunately, no study about using 
the SSI to guide analgesics titration during general anaesthesia has been reported so 
far.  
 
We, therefore, designed the present clinical utility study, which includes two groups,  
SSI-guided analgesia group and standard practice analgesia group, to investigate the 
feasibility of remifentanil administation guided by SSI monitoring during total 
intraveneous anaesthesia with propofol and remifentanil. We hypothesized that: 1) SSI 
may react well to the intensity of stimuli at some major time-points such as loss of 
consciousness (LOC), intubation, maximum stimulation during surgery, extubation, 
emergence from anaesthesia and so on; 2) SSI-guided remifentanil administration 
might result in more stable hemodynamic state, less consumption of remifentanil and 
shorter recovery times. 
 
1.2 Aims and objectives: 
 
A. To investigate the effects of SSI-guided remifentanil delivery on the consumption 
of anaesthetics (remifentanil and propofol), the emergence from anaesthesia and 
the incidence of unwanted events such as hypertension, tachycardia, hypotension, 
movement, etc., druing general anaesthesia. 
B. To further investigate the performance of SSI in assessing the intensity of 
nociceptive stimuli during general anaesthesia. 
C. To compare the performance of SSI in assessing nociceptive stimuli at major 
time-points during general anaesthesia with blood pressure (BP), heart rate (HR), 
state entropy (SE), response entropy (RE), difference between RE and SE 
(RE-SE), bispectral index (BIS) using prediction probability values (Pk values)  
as described by Smith et al. (Smith et al., 1996).  
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2. Materials and methods 
 
This study was approved by the institutional review board of the University Hospital 
Schleswig-Holstein, Campus Kiel. Written consent was obtained from all patients 
who were participated in this study. 
 
2.1 Materials  
 
2.1.1. Surgical Stress Index (SSI) monitor 
The Surgical Stress Index (SSI) monitor has not been available commercially up to 
now. GE Healthcare (GE Healthcare Finland, Helsinki, Finland) supplied the monitor 
to us only for the present study. This monitor is a module of Datex-Ohmeda S/5TM 
which has many modules like M-entropy module, non-invasive blood pressure (NIBP) 
module, electrocardiography module, pulse oximetry (SpO2) module, etc. 
 
Surgical stress index (SSI) is a simple numerical index derived from a 
photoplethysmography finger sensor which was clamped on the index finger. 
Calculation of the SSI was done by 10s intervals and is described elsewhere (Huiku et 
al., 2007) . In brief, the pulse beat interval (HBI) from the pulse plethysmography and 
the pulse plethysmographic wave amplitude (PPGA) were automatically detected and 
the HBI and PPGA time series extracted. The HBI and PPGA were then normalized, 
called HBInorm and PPGAnorm, using the individual patient’s heart rate and PPGA data 
history, and the a priori HBI and PPGA data distributions obtained by pooling data 
from a large adult patient group. This normalization procedure adjusts the individual 
values so that they, after normalization, are in a scale between 0 and 100. As such, the 
SSI is calculated as: 
 
SSI = 100 – (0.33 × HBInorm + 0.67 × PPGAnorm) 
 
A value of 100 represents a very high stress level and a value of 0 represents a very 
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low stress level. 
 
2.1.2 Bispectral Index (BIS) monitor 
The BIS® XP monitor (Aspect Medical Systems, Newton, MA, USA) was used in the 
present study. Calculation of BIS values, a electroencephalography (EEG)-derived 
variable, is based on power spectrum and phase spectrum and quantifies the coupling 
of phase angles of different frequencies. The BIS integrates several disparate 
descriptors of the EEG into a single variable. So, the BIS value is a calculated 
dimensionless variable between 0 and 100. A BIS value of 100 means awake state and 
a value of 0 means deep coma. The recommended range for adequate depth of 
anaesthesia (mainly the hypnosis component) is between 40 and 60 (Manyam et al., 
2007; Song et al., 1997). 
 
BIS-XP sensor (BIS® sensor; AspectTM Medical Systems Inc.) which integrates four 
electrodes was used for obtaining the EEG signal from forehead.  
 
2.1.3 M-entropy module 
The Datex-Ohmeda S/5TM M-entropy module (GE Healthcare Finland, Helsinki, 
Finland) was used to display the state entropy (SE) and the reponse entropy (RE) 
values derived also from the EEG signals. The calculation of the M-entropy was 
described elsewhere (Bein, 2006). M-entropy analyzes the regularity of the spectrum 
distribution in the range from 0 to 47 Hz in which both EEG and EMG activity are 
included with using the frontal electrodes. M-entropy generates two distinct numbers, 
the state entropy and the response entropy. The state entropy is computed over the 
EEG dominant part of the spectrum (0.8–32 Hz) and the response entropy is 
computed over a spectrum range from 0.8 to 47 Hz which includes EEG and EMG 
activity. So, the RE–SE-difference (RE-SE) might then serve as an indicator for EMG 
activation.  
 
Displayed SE values are presented between 0 and 91, a value of 0 means totally 
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suppressed EEG activity and a value of 91 means patient awake. And displayed RE 
values are presented between 0 and 100, a value of 0 means totally suppressed EEG 
and EMG activity and a value of 100 means no suppression of EEG and EMG activity 
at all. Recommended range for adequate anaesthesia for both parameters is from 40 to 
60. 
 
An integrated 3-electrode sensor was used for obtaining the original EEG and EMG 
activity signals. 
 
2.1.4 Datex-Ohmeda Multi-functional S/5TM monitor 
The Datex-Ohmeda Multi-functional S/5TM monitor (GE Healthcare Finland, Helsinki, 
Finland) was used to monitor non-invasive arterial blood pressure (NIBP), 
electrocardiography (ECG), heart rate (HR), pulse oximetry (SpO2) and train-of-four 
(TOF) (for neuromuscular transmission monitoring).  
 
2.1.5 Anaesthetics and Drugs used during anaesthesia 
Propofol: Propofol-®Lipuro 1% (1 ml of emulsion contains 10 mg of propofol); 
chemical name: Phenol,2,6-bis(1-methylethyl), 2,6-Diisopropylphenol; molecular 
formula: C12H18O; molecular weight: 178.27. Manufacturer: B.Braun Melsungen 
AG, 34209 Melsungen, Germany. 
 
Remifentanil: ULTIVA® (remifentanil hydrochloride); 1mg/amp; chemical name: 
3-[4-methoxycarbonyl-4- [(1-oxopropyl)phenylamino]-1-piperidine]propanoic acid 
methyl ester, hydrochloride salt; molecular formula: C20H28N2O5•HCl;  molecular 
weight: 412.91. Manufacturer: GlaxoSmithKline Australia Pty Ltd. 1061 Mountain 
Highway, Boronia victoria 3155. 
 
Rocuronium: Esmoron® (Rocuronium Bromide), chemcial name: 1 - 
[17(beta)-(acetyloxy)-3(alpha)-hydroxy - 2(beta) - (4-morpholinyl) - 5(alpha) – 
androstan - 16(beta) - yl] -1- (2-propenyl) pyrrolidinium bromide; Molecular 
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formula:C32H53BrN2O4; Molecular weight: 609.70. Manufacturer: N.V. Organon, 
Kloosterstreet 6, 5340 BH OSS, Netherland.  
 
Piritramide: Dipidolor®, Chemical name: 1 - (3-cyano-3,3-diphenyl-propyl) – 4 - 
(1-piperidyl) piperidine-4-carboxamide; Molecular formula: C27H34N4O; Molecular 
weight: 430.58; Manufacturer: JASSEN-CILAG GmBH, 41457 Neuss, Germany. 
 
Akrinor®: a mixture of intravenous vasopressors, 1ml of Akrinor® contains 100mg 
cafedrine and 5mg theodrenaline. AWD Pharma, Germany; 
 
Other drugs: Atropine, Urapidil, Metoprolol. 
 
2.2 Methods 
 
2.2.1 Patients and Grouping: 
Eighty patients with ASA physical status Ⅰ or Ⅱ, aged 18~75 yr, schedualed for 
elective ear-nose-throat (ENT) surgery expected to last at least 1h were recruited into 
this study. Exclusion criteria included a history of central nerve systemic (CNS) 
disease (e.g. neurological disorders, head injury, seizure disorders), chronic use of 
psychoactive medication or abuse of alcohol or illicit drugs, and any clinical 
significant cardiovascular, renal, hepatic, or endocrinologic disorders. 
 
We used a computer-generated randomization sheet to assign the 80 patients into two 
groups: SSI Group (SSI guided analgesia group) and Control Group (standard 
analgesia practice group), each group included 40 patients. 
 
2.2.2 Anaesthesia and Monitoring 
 
2.2.2.1 Before Induction of Anaesthesia 
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All patients were premedicated with 20 – 30mg of the benzodiazepine dipotassium 
chlorazepate the evening before and with 3.75 - 7.5mg of midazolam orally 30min 
before surgery.  
 
On arrival in the operating theatre, an intravenous catheter was inserted into a larger 
forearm vein and standard monitoring including non-invasive aterial blood pressure 
(NIBP), 5-lead electrocardiogram (ECG) and pulse oximetery (SpO2) (Datex-Ohmeda 
S/5® monitor, Helsinki, Finland) were applied. All patients in both groups were 
monitored with Bispectral Index (BIS), M-entropy and Surgical Stress Index (SSI). 
After the skin of the forehead had been degreased with alcohol and dry, the BIS® XP 
sensor which integrates four electrodes numbered 1, 2, 3 and 4 respectively was 
positioned on the forehead as recommended by the manufacturer. The number 1 
electrode was at the center of the forehead, approximately 5cm above bridge of nose, 
number 4 was directly above eyebrow and number 3 on left temple between corner of 
eye and hairline, Care was taken to keep the impedances of the BIS® XP sensor below 
7.5KΩ as required by the manufacturer to ensure optimal contact. M-entropy sensor 
which integrates three electrodes was also positioned on the forehead as 
recommended by the manufacturer. The number 1 electrode was attached at the center 
of the forehead, approximately 3cm above the nose and just adjacent to the lower 
edge of the BIS® XP sensor, and number 3 on the right temple area between the 
corner of the eye and hairline. SSI monitoring shared the same sensor of pulse 
oximetry monitor which was clamped on the index finger. The calculation of the SSI 
was done by 10s intervals and described above. 
 
2.2.2.2 Induction of Anaesthesia 
In all patients, anaesthesia was induced with propofol and remifentanil via target 
controlled infusion pump (TCI; Asena® Alaris®, Alaris medical UK ltd. UK). For 
propofol, the pharmacokinetic model of Schnider and collegues, (Schnider et al., 1998) 
and for remifentanil, the pharmacokinetic model of Minto and collegues (Minto et al., 
1997) were used. Predicted effect-site concentration of propofol (PECprop) initially 
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started at 4µg·ml-1 and remifentanil (PECremi) at 4ng·ml-1. After loss of consciousness 
which was defined as the moment the patient dropped a syringe, oxygen was given by 
facemask ventilation, and patients received 0.6mg·kg-1 rocuronium. The trachea was 
then intubated 3min later, and the lungs were ventilated to an end-tidal carbon dioxide 
concentration of 35 mmHg. Immediately after intubation, the predicted effect-site 
concentration of propofol was adjusted by 0.5µg·ml-1 stepwise with 2min intervals to 
keep BIS values between 40-60, which means that the PECprop was increased by 
0.5µg·ml-1 stepwise when BIS values was above 60 and the PECprop was decreased 
0.5µg·ml-1 stepwise when BIS value was below 40 with an interval of 2 min. The 
lower limit of PECprop set for this study was 2µg·ml-1 and no upper limit of PECprop 
was pre-set. The predicted effect-site concentration of remifentanil (PECremi) was not 
adjusted until start of surgery. 
 
2.2.2.3 Maintenance of Anaesthesia and Haemodynamic Control 
Continuous monitoring included heart rate (HR), ventilatory parameters, oxygen 
saturation and end-tidal concentration of carbon dioxide (EtCO2). Systemic 
non-invasive arterial blood pressure (NIBP) was measured intermittently and the 
oxygen saturation was measured by pulse oximetry (SpO2) and maintained above 
95%.  
 
In all patients, irrespective of the individual group assignment, SSI, M-entropy and 
BIS values were monitored continuously and all data from the monitor were captured 
electronically using the software S/5 Collect (GE Healthcare, Helsinki, Finland), 
which collects numerical and waveform data information from selected variables. In 
the Control Group, the SSI monitor was covered with a curtain and invisible to the 
attending anesthesiologist but visible to the recording physician, whereas in the SSI 
Group both SSI and BIS monitors were uncovered. In both groups, M-entropy was 
covered with the same method as the SSI monitor was covered in the Control Group. 
 
The baseline value of NIBP, HR, SSI and BIS was defined as the average of three 
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measurements immediately after patients’ arrival in the operating theatre. NIBP, HR, 
SSI and BIS were recorded every 2.5min, additionally, at some special time-points, 
such as loss of consciousness, tracheal intubation, start of surgery, maximum 
stimulation during surgery, when SSI was >50 or <20, when BIS was >60 or <40, end 
of surgery, eyes opening and at extubation, all the values were also recorded. 
 
During maintenance of anaesthesia, all patients were assessed for signs of inadequate 
anaesthesia, hypotension or bradycardia. Criteria of inadequate anaesthesia were 
modified based on previous studies (Gan et al., 1997; Garrioch and Fitch, 1993; 
Gruenewald et al., 2007; Kreuer et al., 2003) and are listed in Table 1. 
 
Table 1 Criteria for inadequate anaesthesia and hypotension or bradycardia 
Inadequate anaesthesia  
Hypertension Mean arterial blood pressure > 120% of baseline or 
>100mmHg 
  Tachycardia Heart rate > 90 beats·min-1 
  Somatic arousal Coughing, chewing, grimacing 
  Somatic response Purposeful movement  
Hypotension  Mean blood pressure <80% of baseline or < 60mmHg 
Bradycardia Heart rate < 80% of baseline or < 45beats·min-1 
 
In both groups, predicted effect-site concentration of propofol (PECprop) was adjusted 
by stepwise increasing or decreasing 0.5µg·ml-1 to keep the BIS value between 40 and 
60.  
 
In the Control Group, inadequate anaesthesia was treated by increasing the predicted 
effect-site concentration of remifentanil (PECremi) by 1ng·ml-1 stepwise until the 
maximum concentration of 15ng·ml-1 was reached. If this was judged insufficient, 
Urapidil 10mg was given intravenously. Hypotension was treated initially by speeding 
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intravenous liquid infusion, then PECremi was decreased stepwise by 1ng·ml-1 until the 
minimum concentration of 4 ng·ml-1, and finally, 0.5ml Akrinor was given 
intravenously. Atropine 0.5mg was used intravenously for bradycardia. 
 
In the SSI group, PECremi was adjusted by stepwise increasing or decreasing by 
1ng·ml-1 (PECremi range was limited between 4-15 ng·ml-1) to keep the SSI value 
between 20 and 50. Under this circumstance (20 < SSI < 50 and PECremi at 15 ng·ml-1), 
unwanted events during anaesthesia were treated as follows: inhalation of sevoflurane 
with proper concentration for movement; urapidil 10mg i.v. for hypertension; Akrinor 
0.5ml i.v. for hypotension; atropine 0.5mg i.v. for bradycardia and metoprolol 2mg i.v. 
for tachycardia, repeated if necessary.  
 
2.2.2.4 Recovery Period 
To facilitate rapid emergence from anaesthesia, 15min before the expected end of 
surgery, propofol was reduced in all patients according the experience of the attending 
anesthesiologist, whereas the remifentanil TCI remained unchanged until end of 
surgery. In the meantime, all patients received 0.1mg·kg-1 of the opioid piritramide for 
postoperative analgesia. Both propofol and remifentanil TCI were discontinued at the 
end of surgery.  
 
The end of surgery was defined as the final surgical suture. Emergence from 
anaesthesia was assessed by measuring time to spontaneous opening of eyes, and to 
extubation.  
 
Postoperative care in the recovery room was supervised by a nurse who was blinded 
to study protocol. In the recovery room, the modified Aldrete-Score (Table 2), 
postoperative nausea and vomiting, and pain [using a 0-100 numerical pain intensity 
rating scale (NRS)] were recorded. On the first postoperative day, all patients were 
asked by a blinded investigator if they had any memory or awareness during 
anaesthesia, and the level of satisfaction with the whole procedure was investigated 
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using a 0-100 scale (0 means the worst satisfaction and 100 means best satisfaction). 
 
 
Table 2. Modified Aldrete-Score 
Modified Aldrete-Score 
Activity 2 Moves all extremities voluntarily or on command 
 1 Moves two extremities 
 0 Unable to move extremities 
Respiration 2 Breathes deeply and coughs freely 
 1 Requires assistance, shallow or limited breathing 
 0 Apnea 
Circulation 2 ±20mmHg of prenaesthetic level 
 1 ±20~50mmHg of preanaesthetic level 
 0 ±over 50mmHg of preanaesthetic level 
Consciousness 2 Fully awake 
 1 Arousable on calling 
 0 Not responding 
Oxygen saturation 2 SpO2> 92% on room air 
 1 SpO2>92% with O2 supplementation 
 0 SpO2<92% with O2 supplementation 
 
2.2.3 Endpoints and Statistical Analysis 
 
2.2.3.1 Endpoints and Sample Size 
The primary endpoint of this study was defined as the time to open eyes. A sample 
size of 40 was based on a previous study (Kreuer et al., 2003), assuming a difference 
in emergence of 3min at α= 0.05 with 90% power. Secondary endpoints were the 
differences in Pk between SSI, BIS, SE, RE, RE-SE, mean BP, and HR for predicting 
the nociceptive – anti-nociceptive balance at different event related time points: 
awake vs loss of consciousness; normal stimulation (recorded at 5min before 
maximum stimulation) vs maximum stimulation; anaesthesia (recorded at the 
discontinuation of propofol and remifentanil infusion) vs eyes opening. 
 
2.2.3.2 Software for Statistical Analysis and Data Presentation 
SPSS 11.5 for windows statistical package (SPSS inc. Chicargo, IL, U.S.A) was used 
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for statistical analysis and GraphPad Prism software (Version 4.0, GraphPad Software 
Inc., San Diego, CA, USA) was used for figures. PkMACRO and PkDMACRO 
(offered by Prof. Smith) spreadsheets were used for Pk value calculation and 
comparing. All tests were two-tailed with statistical significance defined as P < 0.05. 
 
Data were presented as mean ± SD for numerical data, range or number for nominal 
data and mean ± SE for Pk values. 
 
2.2.3.3 Prediction Probability 
Comparison of the performance of SSI, BIS, SE, RE, RE-SE, mean BP, and HR for 
predicting the nociceptive-anti-nociceptive balance (see 2.2.3.1) was performed with 
prediction probability (Pk) (Smith et al., 1996). Pk was calculated using PkMACRO as 
described by Smith et al (Smith et al., 1996). The jackknife method was used to 
compute the standard error of the estimate. A value of Pk = 1 or 0 means a 100% 
correct prediction of a certain clinical state or other state by a specific monitor, 
whereas a value of 0.5 means only a 50:50 chance. Comparison between the Pk values 
of different variables was performed with the PkDMACRO (Smith et al., 1996). 
 
2.2.3.4 Correlations 
Correlations between SSI or RE-SE and HR or mean BP, BIS and SE, and so on were 
evaluated by nonparametric Spearman rank correlation for all data pairs at four major 
time-points: P1 = baseline before induction of anaesthesia; P2 = immediately after 
tracheal intubation; P3 = at maximum surgical stimulation; P4 = 15min after 
maximum surgical stimulation. 
 
2.2.5 Logistic Regression 
For SSI and BIS, the logistic regression was calculated for the probability of loss of 
consciousness, intubation, maximum surgical stimulation and emergence from 
anaesthesia. The Hill coefficients were calculated to describe the steepness of those 
relationships. 
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2.2.3.6 Other Statistical Analysis 
For demographic data, consumption of anaesthesic, duration of anaesthesia and 
surgery, times fraction of SSI and BIS, variables such as SSI, BIS, SE, RE, RE-SE, 
mean BP, HR and so on at major time-points, independent samples student t test 
(normally distributed) and Mann-Whitney U test (non-normally distributed) or 
one-way analysis of variance with Student-Newman-Keuls test (multiple comparisons) 
were used for numerical data and chi-square test was used for the nominal data.  
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3. Results 
3.1 Demographic Data 
All 80 patients (40 patients in each group) enrolled in the present study were included 
into the final analysis. There were no differences in patients’ demographic data such 
as age, weight, height, and duration of anesthesia, duration of surgery, and duration 
from intubation to start of surgery between groups (Table 3). 
 
Table 3. Demographic Data  
 SSI Group (n =40) Standard Practice (n =40) 
Age (yr) 46.8±16.6 46.0±17.5 
Height (cm) 172.9±17.8 170.8±9.4 
Weight (Kg) 78.3±11.5 74.6±16.6 
Gender-M/F (n) 13/27 21/19 
ASA / (n) 18/22 19/21 
Duration of anaesthesia (min) 152.0±67.2 173.0±83.8 
Duration of surgery (min) 109.0±60.6 131.7±81.4 
Intubation to start of surgery (min) 24.1±7.9 24.6±9.6 
Values are mean ± SD or numbers of patients. Data are not significantly different 
between groups. P > 0.05. 
 
3.2 Recovery Times and Anaesthetics Consumption 
Although the times to open eyes seemed shorter in the SSI group compared to the 
standard analgesia practice group (8.9 ± 4.3 vs 10.6 ± 4.3 min), difference between 
groups was not statistically significant (P > 0.05; Table 4). A Kaplan-Meier survival 
analysis is shown in Figure 1. This figure shows the cumulative percentage of patients 
who remained unconscious (not open eyes) after discontinuation of propofol and 
remifentanil infusion, indicating a faster awakening in the SSI-guide analgesia group 
but with no significance when compared with the standard analgesia practice group (P 
> 0.05). 
Table 4. Recovery Times  
 SSI Group(n =40) Standard Practice (n =40) 
Eyes-openning (min) 8.8±3.8 10.6±4.3 
Extubation (min)   9.8±4.4 11.2±4.6 
Values are mean ± SD, no significant difference between groups (independent 
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samples student t test). P > 0.05. 
Figure. 1 
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Figure. 1. Cumulative probability of patients’ remaining unconsciousness (before opening 
eyes) after discontinuation of anaesthetics (propofol and remifentanil) infusion in SSI-guided 
analgesia Group (－▲－; shaded area) or Standard analgesia practice Group (--■--; shaded 
area) using Kaplan-Meier survival analysis. Log-rank differences were not statistically 
significant between groups. P > 0.05. 
 
Remifentanil consumption (averaged normalized infusion rate calculated from 
induction to discontinuation of anaesthetics) was significantly lower in SSI group 
when compared to standard practice group (9.5 ± 3.8 µg · kg-1 · h-1 vs 12.3 ± 5.2 
µg · kg-1 · h-1, P < 0.05) (Table 5), whereas there was no difference in propofol 
consumption (averaged normalized infusion rate) between groups (5.3 ± 1.5 
mg · kg-1 · h-1 in the SSI-guided analgesia group and 5.6 ± 1.5 mg · kg-1 · h-1 in the 
standard analgesia practice group, respectively, P > 0.05) (Table 5). 
 
Table 5. Characteristics of Propofol and Remifentanil Consumption 
 SSI Group (n =40) Standard Practice (n =40) 
For one patient   
  Propofol consumption (mg) 1018.5±345.8 1157.7±558.8 
  Remifentanil consumption (µg) 2063.5±1579.5 2634.4±1792.1 
For one patient normalized [= total anaesthetics dose / duration of anaesthesia (h) / weight (Kg)] 
  Propofol consumption (mg·kg-1·h-1) 5.3±1.5 5.6±1.5 
  Remifentanil consumption (µg·kg-1·h-1) 9.5±3.8 * 12.3±5.2 
Reduction when compared to standard -22.8 NA 
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practice (%) 
Values are mean ± SD.  
* P < 0.01, compared to standard practice group. (independent samples student t test between 
groups). 
NA = Not Applicable. 
 
Moreover, the predicted effect-site concentrations of remifentanil (PECremi) were 
lower at the time-point of S+30, S+45, and S+60 (S+30 means 30min after start of 
surgery, S+45 and S+60 have the same meaning to S+30) in the SSI analgesia group 
than that at the corresponding time-points in the standard analgesia practice group (P 
< 0.05) (Figure 2A), whereas the predictive effect-site concentrations of propofol 
(PECprop) were comparable at all major time-points during maintenance of anaesthesia 
between groups (P > 0.05). (Figure 2B).  
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Figure 2. Changes in predicted effect-site concentrations of propofol and remifentanil in 
SSI-guided analgesia group (●) or standard analgesia practice group () at major time points 
during anaesthesia: baseline (Base), loss of consiousness (LOC), intubation (Intu), start of 
surgery (S), Maximum stimulation (Max), end of propofol and remifentanil (E), eyes 
openning (OE) and extubation (Extu). Values are mean (SD); *P < 0.05 when compared with 
standard analgesia practice group. 
 
3.3 Surgical Stress Index and Bispectral Index 
Both SSI values and BIS values were collected in all patients, irrespective of the 
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individual group assignment, and are displayed in Figure 3. SSI values were higher at 
various time-points (start of surgery, 15min after start of surgery, 45min after start of 
surgery and the end of the surgery) during anaesthesia in SSI group than that at the 
corresponding time-points in the standard analgesia practice group (Figure 3A) (P < 
0.05). whereas the BIS values were comparable at all major time-points during 
anaesthesia between groups (Figure 3B) (P > 0.05). 
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Figure 3. Changes in surgical stress index (SSI) and bispectral index (BIS) values in 
SSI-guided analgesia group (●) or standard practice group () at major time points during 
anaesthesia: baseline (Base), loss of consciousness (LOC), intubation (Intu), start of surgery 
(S), Maximum stimulation (Max), end of propofol and remifentanil (E), eyes opening (OE) 
and extubation (Extu). Values are mean (SD); *P < 0.05 when compared with standard 
practice analgesia group. 
 
Additionally, we analyzed the time fractions of actual SSI or BIS values collected 
during maintenance of anaesthesia (Table 6): The time fractions of actual SSI value < 
20 and SSI value > 50 were significantly lower in the SSI-guided analgesia group 
than in the standard analgesia practice group (12.4% vs 24.4%; 4.3% vs 12.1%, 
respectively, P < 0.05). Correspondingly time fractions of SSI values between 20 and 
50 (20<SSI<50) were higher significantly in the SSI-guided analgesia group than in 
the standard analgesia practice group (83.2% vs 62.8%, respectively, P < 0.01). In 
contrast the time fractions of BIS value < 40 and >60, or between 40 to 60 were 
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comparable between groups (30.0% vs 23.7%, 8.7% vs 5.2%, and 72.7% vs 76.9% in 
the SSI-guided analgesia group and standard analgesia practice group, respectively. (P 
> 0.05) (Table 6). 
 
Table 6. Time Fractions of Actual SSI and BIS Values during Anaesthesia Maintenance  
 SSI Group (n =40) Standard Practice (n =40) 
SSI < 20 (%) 12.4 ± 5.7 * 24.4 ± 7.5 
SSI > 50 (%) 4.3 ±1.5 * 12.1 ± 4.5 
20 < SSI < 50 (%) 83.2 ± 9.2 * 62.8 ± 7.9 
BIS < 40 (%) 30.0 ± 5.4 23.7 ± 5.0 
BIS > 60 (%) 8.7 ± 3.5 5.2 ± 3.0 
40 < BIS < 60(%) 72.7 ± 10.0 76.9 ± 10.1 
Data are mean ± SD. * P < 0.05, compared to standard analgesia practice group. (independent 
samples student t test between groups). 
 
3.4 Predictive Probabilities (Pk) of anaesthesia depth indicators to Predict the State 
of Nociception and Hypnosis 
We calculated the prediction probabilities of surgical stress index (SSI), bispectral 
index (BIS), state entropy (SE), response entropy (RE), RE-SE difference, mean 
arterial blood pressure (MBP), heart rate (HR) to predict certain states: awake vs loss 
of consciousness (LOC), loss of consciousness (LOC) vs intubation, nomal 
stimulation (1min before maximum stimulation which was defined by surgeon 
intra-operatively) vs maximum stimulation, anaesthesia (at the end of the anaesthetics 
administration) vs emergence from anaesthesia (eyes opening) in both groups.  
 
3.4.1 Pk values of SSI, BIS, MBP and HR (Table 7) 
For predicting loss of consciousness (LOC), only the BIS had a Pk value > 0.90. The 
Pk value of the SSI was similar to that of BIS (0.88 vs 0.90, P > 0.05), whereas the Pk 
values of both MBP and HR were significantly lower than that of the BIS and the SSI 
(0.78 and 0.60 vs 0.91 and 0.88. P < 0.01).  
 
For predicting the state of intubation, the Pk value of the SSI was the highest among 
SI, BIS, MBP and HR (0.87 vs 0.60, 0.69, 0.65, respectively. P < 0.01). 
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For predicting the state of the maximum stimulation during surgery, the Pk value of 
the SSI was also the highest among SSI, BIS, MBP and HR (0.85 vs 0.54, 0.60, 0.51, 
respectively. P < 0.01). 
 
For predicting the state of emergence from anaesthesia (eyes opening), the Pk value of 
the BIS was the highest among BIS, SSI, MBP and HR (0.95 vs 0.81, 0.84, 0.76, 
respectively. P < 0.01). 
 
Table 7. Prediction Probabilities (Pk) of Different Variables  
  SSI BIS MBP HR 
All patients (n = 80) 0.88±0.03 0.91±0.02 0.78±0.04*§ 0.60±0.05*§# 
SSI  Group (n= 40) 0.92±0.03 0.90±0.03 0.75±0.06 0.57±0.07 
Awake 
 vs  
LOC Standard practice (n= 40) 0.83±0.05 0.91±0.03 0.82±0.05 0.62±0.06 
 
     
All patients (n = 80) 0.87±0.03 0.60±0.05* 0.69±0.04* 0.65±0.04* 
SSI  Group (n= 40) 0.85±0.04 0.61±0.07 0.67±0.06 0.62±0.07 
LOC 
 vs 
Intubation Standard practice (n= 40) 0.91±0.03 0.57±0.06 0.70±0.06 0.68±0.06 
      
All patients (n = 80) 0.85±0.03 0.54±0.05* 0.60±0.05* 0.51±0.05* 
SSI  Group (n= 40) 0.90±0.04 0.54±0.07 0.58±0.07 0.52±0.07 
Normal 
 vs  
Max stimulation Standard practice (n= 40) 0.82±0.05 0.55±0.07 0.61±0.06 0.50±0.07 
      
All patients (n = 80) 0.81±0.04 0.95±0.02* 0.84±0.03§ 0.76±0.04§ 
SSI  Group (n= 40) 0.83±0.05 0.95±0.02 0.81±0.05 0.82±0.05 
Anaesthesia  
vs  
Eye-opening Standard practice (n= 40) 0.80±0.05 0.93±0.03 0.88±0.04 0.71±0.06 
This table shows the prediction probabilities (Pk values) of SSI, BIS, MeanBP and HR for 
predicting the following states: awake vs loss of consciousness (LOC); loss of consciousness 
(LOC) vs intubation; normal stimulation (Normal) (1min before maximum surgical 
stimulation) vs maximum surgical stimulation (Max stimulation) which was defined by 
surgeon intraoperatively; anaesthesia vs eye-opening in all patients in both group. The 
comparisons of Pk values between groups were only performed on pooled data of both groups. 
* P < 0.01 compared with SSI; §P < 0.01 compared with BIS; # P < 0.01 compared with BP. 
No differences were found between groups for all variables. 
 
Additionally, the BIS value of the 95% possibility for loss of consciousness was 40 
(95%CI: 18 - 48) (Figure 4A) and for emergence from anaesthesia (eyes opening) was 
75 (95% CI: 71 - 81) (Figure 4B). The SSI value of the 95% possibility for intubation 
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was 59 (95% CI: 53 -70) (Figure 5A) and for the maximum stimulation during 
surgery was 60 (95% CI: 49 ~91) (Figure 5B). 
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Figure 4. Logistic regression curve shows the probability of BIS to predict two endpoints, loss 
of consciousness (LOC) from awake (A) and emergence or awake from anaesthesia (B) with 
all the patients in both groups. Dotted lined indicate the 95% probability. 
 
Figure 5 
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Figure 5. Logistic regression curve shows the probability of SSI to predict two endpoints, 
intubation (A) and maximum operative stimulation (B) with all patients in both groups. 
Dotted lined indicate the 95% probability. 
 
3.4.1 Pk values of SSI, SE, RE and RE-SE (Table 8)  
For predicting the state of loss of consciousness (LOC), all the four parameters had 
similar Pk values (0.88, 0.89, 0.88 and 0.95 for SSI, SE, RE and RE-SE difference, 
respectively, P > 0.05). 
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For predicting the state of intubation, the Pk values of SSI were significantly higher 
than that of SE, RE and RE-SE difference (0.87 vs 0.59, 0.55, 0.51, respectively. P < 
0.01). 
 
For predicting the state of the maximum surgical stimulation, the Pk values of SSI 
were also significantly higher than that of SE, RE (0.85 vs 0.51and 0.56, P < 0.01) 
and RE-SE difference (0.85 vs 0.79, P < 0.05). RE-SE difference had a better 
prediction probability than SE and RE (0.79 vs 0.51, 0.56, P < 0.05). 
 
For prediction of the emergence from anaesthesia (eyes opening), SSI had a worse 
prediction probability than SE, RE and RE-SE difference (0.80 vs 0.97, 0.98, 0.97, 
respectively. P < 0.01). 
 
Table 8. Prediction Probabilities (Pk) of Different Variables  
  SSI SE RE RE-SE 
All patients (n = 80) 0.88±0.03 0.89±0.04 0.88±0.04 0.95±0.03 
SSI  Group (n= 40) 0.92±0.03 0.91±0.04 0.89±0.04 0.92±0.04 
Awake 
 vs  
LOC Standard practice (n= 40) 0.83±0.05 0.90±0.02 0.89±0.03 0.93±0.02 
 
     
All patients (n = 80) 0.87±0.03 0.59±0.07* 0.55±0.07* 0.51±0.07* 
SSI  Group (n= 40) 0.85±0.04 0.55±0.07 0.60±0.07 0.51±0.07 
LOC 
 Vs 
Intubation Standard practice (n= 40) 0.91±0.03 0.56±0.05 0.58±0.05 0.51±0.05 
      
All patients (n = 80) 0.85±0.03 0.51±0.07*# 0.56±0.07*# 0.79±0.05§ 
SSI  Group (n= 40) 0.90±0.04 0.52±0.07 0.63±0.06 0.71±0.06 
Normal 
 vs  
Max stimulation Standard practice (n= 40) 0.82±0.05 0.52±0.05 0.59±0.05 0.76±0.04 
      
All patients (n = 80) 0.81±0.04 0.98±0.01* 0.98±0.01* 0.97±0.02* 
SSI  Group (n= 40) 0.83±0.05 0.96±0.02 0.98±0.01 0.92±0.03 
Anaesthesia  
vs  
Eye-opening Standard practice (n= 40) 0.80±0.05 0.97±0.01 0.98±0.01 0.94±0.02 
This table shows the prediction probabilities (Pk values) of SSI, SE, RE, RE-SE difference for 
predicting the states: awake vs loss of consciousness (LOC); loss of consciousness (LOC) vs 
intubation; normal stimulation (Normal) vs maximum surgical stimulation (Max stimulation) 
which was defined by surgeon intraoperatively; anaesthesia vs eye-opening in all patients in 
both groups. The comparisons of Pk values between groups were only performed on pooled 
data of both groups. 
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* P < 0.01 compared with SSI; §P < 0.05 compared with SSI; # P < 0.01 compared with 
RE-SE difference. No differences were found between groups for all variables. 
 
3.5 Unwanted Events during Anaesthesia 
Patients in the standard analgesia group had significantly more hypertension (84 vs 11, 
P < 0.01), hypotension (67 vs 5, P < 0.01), bradycardia (111 vs 23, P < 0.01) and 
movement (14 vs 3, P < 0.01). Total number of unwanted events was 278 vs 42, P < 
0.01, (Table 9). However, we could not find any difference in mean blood pressure 
and heart rate at all the major time-points between groups (Figure 6). 
 
Table 9. Incidence of Unwanted Events Happened during the Intra-operative 
Period 
 SSI Group (n =40) Standard Practice (n =40) 
Hypertension 11 (0.28) * 84 (2.1) 
Hypotension 5 (0.13) * 67 (1.68) 
Tachycardia 0 (0) 2 (0.05) 
Bradycardia 23 (0.57) * 111 (2.78) 
Movements 3 (0.08) * 14 (0.35) 
Total unwanted events 42 (1.05) * 278 (6.95) 
Data are numbers of unwanted event during surgery. Data in brackets are numbers of 
unwanted events per patient. * P < 0.01 when compared with Standard Practice Group. 
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Figure 6. Changes in mean non-invasive arterial blood pressure (NIBP) and heart rate (HR)in 
SSI-guided analgesia group (●) or standard practice group () at major time points during 
anaesthesia: baseline (Base), loss of consciousness (LOC), intubation (Intu), start of surgery 
(S), Maximum surgical stimulation (Max), end of propofol and remifentanil (E), eyes opening 
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(OE) and extubation (Extu). Values are mean (SD); No significant difference between group 
(P > 0.05). 
 
3.6. Postoperative Period 
Postoperative pain, nausea and vomiting, modified Aldrete-Score, total satisfaction in 
the recovery room and on the first day after surgery are shown in Table 10. There 
were no any significant differences in intensity of postoperative pain (VAS), 
postoperative nausea and vomiting (PONV), modified Aldrete-score, level of total 
satisfaction and physiological variables (P > 0.05). And no patient reported 
intraoperative recall. 
 
Table 10. Postoperative Observation (recovery room and on the first day after surgery) 
 SSI Group (n =40) Standard Practice (n =40) 
Aldrete Score 6.3 (2 - 10) 6.2 (2 - 10) 
VAS 4.2 (1 -10) 4.3 (1 -10) 
PONV 12 (30%) 14 (35%) 
Satisfaction 95 (80 - 100) 93 (75 -100) 
Data are median (range) or numbers (proportion). No differences between groups (P > 0.05). 
Aldrete Score = modified aldrete score, refer to Table 2. 
VAS = visual analogue score, scaled from 0 to 10 and 0 means no pain and 10 means the 
maximum intensity of pain. 
PONV = postoperative nausea and vomiting. 
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4. Discussion 
 
In the present prospective, randomized, controlled clinical study, we investigated the 
utility of surgical stress index (SSI) for guiding the titration of remifentanil during a 
constant hypnotic level controlled by bispectral index (BIS) guided propofol infusion 
during general anaesthesia with propofol and remifentanil in patients undergoing 
ear-nose-throat (ENT) surgery. Our results demonstrate that SSI-guided remifentanil 
titration resulted in a significant reduction of remifentanil consumption, and less 
incidence of unwanted events (hypertension, hypotension, tachycardia and movement) 
during surgery when compared with standard practice protocol. 
 
Our results might be of great interest because getting an appropriate analgesic 
delivery has been a pursuit for all anesthesiologists, which has not been reached so far. 
In the present study, we used SSI and BIS to guide remifentanil and propofol infusion, 
respectively, during general anaesthesia, in other words, we monitored separately the 
balance of nociception – anti-nociception (stress and analgesic) and hypnosis, which 
are the main components of general anaesthesia. To our best knowledge, this is the fist 
time that such a study has been performed. 
 
Up to now, many efforts have been made to develop a method to guide analgesic 
administration during general anaesthesia. In a previous study (Mathews et al., 2007), 
Mathews et al. concluded that remifentanil titration during general anaesthesia may be 
guided by the difference between RE and SE (RE-SE). However, they did not 
investigate the remifentanil consumption during anaesthesia. Gruenewald et al. also 
tried to use the RE-SE difference to guide remifentanil titration and found that RE-SE 
difference guided remifentanil titration resulted in lower remifentanil consumption 
when compared the standard practice group during propofol – remifentanil 
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anaesthesia (Gruenewald et al., 2007). In their study, however, the propofol infusion 
was controlled by SE in the RE-SE guided group whereas there was no guiding 
monitor for propofol infusion in the standard practice group, which is in contrary to 
the protocol of our present study in which we used BIS for guiding propofol infusion 
in both group. Furthermore, the RE-SE difference itself has not been validated to be a 
tool for assessing the balance of nociception – anti-nociception.  
 
It is well known that hypnosis and nociception are partly interrelated: deep hypnosis 
suppresses nociception (Antognini et al., 2000a; Singh et al., 1999), and significant 
nociception causes arousal (Antognini et al., 2000a; Antognini et al., 2000b; Guignard 
et al., 2000; Ropcke et al., 2001). Additionally, hypnotic agents and analgesics have 
also a synergistic effect with each other. Kern et al. has revealed the tremendous 
synergy between remifentanil and propofol. BIS is a well-accepted tool to monitor the 
hypnotic level and BIS-guided anaesthesia has been proved to reduce the risk of 
awareness during general anaesthesia (2006; Myles et al., 2004). A BIS value of 40 to 
60 has been recommended as a ‘ideal’ range (2006; Manyam et al., 2007; Song et al., 
1997). Therefore, the facts shown above could explain why we chose a range of 40 < 
BIS < 60 for guiding propofol titration to keep hypnosis at a constant depth in both 
groups in our present study. We suggest that in such a state, the results of remifentanil 
consumption resulting from SSI-guidance might be more credible. 
 
In our study, the consumption of remifentanil (averaged normalized infusion rate) was 
significantly lower in the SSI-guided analgesia group when compared with the 
standard analgesia practice group. This might be explained initially by the higher 
performance of SSI in assessing the nociceptive stimulus during general anaesthesia. 
Huiku et al. proved that SSI correlates positively to surgical nociceptive stimuli and 
negatively to analgesic drug concentration during propofol-remifentanil anaesthesia 
(Huiku et al., 2007). Struys et al. and Wennervirta et al. further demonstrated that SSI 
has a better performance in measuring nociception – anti-nociception balance than SE, 
RE, BP, heart rate and pulse wave amplitude (PPGA) (Struys et al., 2007; Wennervirta 
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et al., 2008). In accordance with their findings, the prediction probability (Pk) for SSI 
to predict the maximum surgical stimulation was 0.85, which was significantly higher 
than that of SE, RE, RE-SE, HR and BP in the present study. Secondly, the time 
fractions of actual SSI value > 50 and SSI value < 20 during maintenance of 
anaesthesia were significantly lower in the SSI-guided analgesia group than in the 
standard analgesia group, whereas the time fractions of actual SSI value between 20 
and 50 were significantly higher in the SSI-guided analgesia group. This indicates that 
SSI-guided analgesia provided a stable SSI level during maintenance of anaesthesia, 
in other words, it resulted in a optimal balance of nociception – anti-nociception due 
to the good correlation between SSI values and nociception – anti –nociception during 
general anaesthesia. Thirdly, the SSI values at some major time-points during 
anaesthesia were significantly higher, correspondingly the predicted effect-site 
concentrations of remifentanil (PECremi) at some major time-points during anaesthesia 
were significantly lower in the SSI-guided analgesia group than in the standard 
analgesia group. These results may be considered to conclude that the PECremis may 
be overdose at some time-points in the standard analgesia group which in turn 
resulted in the higher consumption of remifentanil. 
 
The choice of the range of SSI between 20 and 50 (20 < SSI < 50) for guiding 
remifentanil titration in the present study might be questioned because an optimal 
range of SSI during anaesthesia has not been recommended yet (Wennervirta et al., 
2008). We chose the range of 20 < SSI < 50 for guidance of remifentanil titration 
during maintenance of anaesthesia in the SSI-guide analgesia group according to the 
initial findings of a previous study (Struys et al., 2007). In this study it was shown that 
SSI values were around 20 at baseline when there was no simulation and PECremi was 
at a high level, and SSI values were over 50 after stimulation when the PECremi was at 
a lower level. In the present study, the feasibility of the range of 20 < SSI < 50 used 
for guiding analgesic titration during general anaesthesia might also be justified, at 
least to some extent, by the fact that the hemodynamic state was more stable (low 
incidence of hypertension, hypotension and bradycardia) and less movement episodes 
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in the SSI-guided analgesia group when compared with standard analgesia group. 
Moreover, we also analyzed the SSI value of the 95% possibility after intubation and 
after the maximum operative stimulation using binary logistic regression. The results 
showed the SSI value of the 95% possibility for intubation was 59 and for the 
maximum surgical stimulation was 60, which may further support retrospectively our 
choice of the range of 20 < SSI < 50 for guidance of analgesic administration during 
general anaesthesia. However, whether the range of 20 < SSI < 50 is “ideal” needs to 
be further investigated by more clinical studies. 
 
Interestingly, although the recovery times (times to opening eyes) seemed shorter in 
the SSI-guided analgesia group than in the standard analgesia group, the differences 
between groups did not reach the level of statistical significance. This is in contrary to 
previous studies (Gan et al., 1997; Gruenewald et al., 2007) in which BIS or Entropy 
were used to guide propofol administration or RE-SE difference to guide remifentanil 
administration, and found BIS-guided or Entropy-guided anaesthesia resulted in faster 
emergence. In their studies, lower consumption of propofol was in the BIS- or 
Entropy-guided group, whereas in our study, the consumption of propofol was 
comparable between groups since both groups were guided by BIS with respect to 
propofol titration. The comparison of our study and the previous studies with respect 
to recovery time and anaesthesic consumption indicates that the emergence time may 
be determined mainly by the propofol consumption but little by the remifentanil 
consumption during general anaesthesia. 
 
For evaluation of the performance for SSI to assess nociception – anti-nociception 
balance, we used the well accepted method, prediction probability Pk, developed by 
Smith et al. (Smith et al., 1996). The results showed that the Pk values for SSI to 
predict maximum surgical stimulation and intubation were higher than for other 
variables studied, BIS, SE, RE, RE-SE, BP and HR, which is in accordance with other 
previous studies (Ahonen et al., 2007; Huiku et al., 2007; Wennervirta et al., 2008). 
This further proved that the EEG-derived parameters, BIS and Entropy, mainly 
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monitor the hypnotic state. BP and HR have been traditionally considered to assess 
the depth of nociception – anti-nociception balance. However, in the present study, the 
Pk values for BP and HR to predict maximum surgical stimulation and intubation were 
almost near to 0.5 which means that their predictive power is not better than ???. 
Given that the stimulation intensity during surgery varies frequently, the intermittent 
measurement of blood pressure might be a reason of why the performance of BP in 
detecting the nociceptive stimulus level was not good in the present study. HR was 
found to be lower with remifentanil anaesthesia by increasing vagal tone (Komatsu et 
al., 2007). Gurkan et al. concluded that remifentanil causes direct negative 
chronotropic and positive inotropic effect (Gurkan et al., 2005). Therefore, the HR 
might be insensitive to surgical stimulation during remifentanil anaesthesia, in other 
words, the performance of HR in detecting the nociception – anti-nociception might 
be low. When considering the results, however, it must be kept in mind that exact 
numeric Pk values are only comparable between identical study condition only 
(Gurkan et al., 2005; Wennervirta et al., 2008). 
 
The present study has limitations. First, it might be argued that the investigator was 
biased in the standard analgesia practice group. Of course, ‘learning contamination’ 
bias (Roizen and Toledano, 1994) must be addressed as a problem of unintended 
improvement of standard clinical practice patterns happened with the introduction of a 
new monitor device, thereby reducing the difference of results in a randomized trial 
(Kreuer et al., 2003). In the present study, however, the protocol of analgesic 
administration was strictly pre-determined in both groups. More importantly, in the 
standard analgesia practice group, the adjustment of predicted effect-site 
concentration of remifentanil (PECremi) was clearly defined. Almost all the endpoints 
for adjustment of remifentanil titration were quantified, e.g. increasing PECremi at 
mean BP over 100mmHg or HR over 90 or movement, decreasing PECremi at mean 
BP below 60 or HR below 45. Therefore, significant investigator bias can obviously 
excluded as a confounding factor for the explanation of the present results. 
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Second, BP was measured intermittently in our study. The BP values we collected 
may have not responded to every episode happened during anaesthesia because most 
of the episodes, e.g. movement, maximum surgical stimulation, have a very short 
duration and last only some seconds. Therefore, if BP had been measured 
continuously with an arterial line, the BP values probably would have reacted more 
timely to changes in nociception. Thereby, the continuous invasive BP might be as 
good as SSI in predicting the nociception –anti –nociception balance (Wennervirta et 
al., 2008). 
 
Third, as described by Wennervirta (Wennervirta et al., 2008), rocuronium used in our 
study may have had an influence the heart rate. Moreover, muscle relaxants may also 
influence BIS values (Bonhomme and Hans, 2007; Pope et al., 2000). Given that we 
used rocuronium comparable in both groups, it could be thought that the results have 
not been influenced substantially. 
 
In conclusion, we investigated the effects of SSI guidance on the remifentanil titration 
in comparison to a standard analgesia practice group during propofol-remifentanil 
anaesthesia. SSI-guided remifentanil titration resulted in lower remifentanil 
consumption, more stable hemodynamic state, lower incidence of unwanted events 
and comparable recovery times when compared to standard clinical analgesia practice. 
Furthermore, we also found that SSI had better performance in detecting maximum 
surgical stimulation and intubation than SE, RE, RE-SE, BIS, BP and HR. More 
studies are needed to further investigate for the usefulness of SSI in daily clinical 
practice. 
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5. Summary 
 
It is well-known that excessive intraoperative stress (nociceptive stimulus) results in 
various physiological changes, such as immunological, haemodynamic or endocrine 
‘stress response’, which thereby may compromise patients’ outcome, influence the 
length of hospital stay and overall costs of hospital care. To achieve an appropriate 
balance of nociception – anti-nociception during general anaesthesia is very important 
and necessary.  
 
Achieving an appropriate balance of  nociception – anti-nociception during general 
anaesthesia depends on an indicator which can assess accurately the balance of  
nociception – anti-nociception to guide analgesic delivery. Surgical stress index (SSI) 
has been proven to have a better performance in assessing the balance of  
nociception – anti-nociception during general anaesthesia compared with more 
traditional variables like blood pressure and heart rate. 
 
We designed a prospective, randomized, controlled clinical study, which included two 
groups – SSI-guided analgesia group and standard analgesia practice group, to 
investigate the effect of SSI-guided analgesia on recovery time, anaesthetics 
consumption, incidence of unwanted events during general anaesthesia with propofol 
and remifentanil during a constant hypnotic level.  
 
The results demonstrated that SSI-guided analgesia resulted in a significant reduction 
of remifentail consumption, less incidence of unwanted events (hypertension, 
hypotension, tachycardia and movement) and in a similar recovery time during 
general anaesthesia when compared with the standard analgesia practice protocol. 
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Our study also further proved that SSI has a better performance in detecting the 
balance of nociception – anti-nociception than state entropy (SE), response entropy 
(RE), difference between response entropy and state entropy (RE-SE), blood pressure 
and heart rate during general anaesthesia. 
 
However, the ‘ideal’ range of SSI for guiding analgesia needs to be further 
investigated. 
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